TITLE

Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults

AUTHOR(S)
Watson-Creed, Gaynor; Saunders, Andrea; Scott, Jeffrey; Lowe, Luis; Pettipas, Janice; Hatchette, Todd F.
PUB. DATE
August 2006
SOURCE
CMAJ: Canadian Medical Association Journal;8/29/2006, Vol. 175 Issue 5, p483
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Before the widespread use of vaccine, mumps was the most common cause of viral meningitis (up to 10% of mumps infections). Vaccination programs have resulted in a drop of more than 99% in the number of reported mumps cases in the United States and Canada. Although rare in Canada, outbreaks have recently occurred throughout the world, including a large outbreak in the United Kingdom, where more than 56 000 cases were reported in 2004-2005. Methods: Two recent outbreaks in Nova Scotia were investigated by public health officials. Cases were defined by laboratory confirmation of infection (i.e., isolation of mumps virus by culture) or clinical diagnosis in people epidemiologically linked to a laboratory-confirmed case. The people infected were interviewed to determine possible links and to identify contacts. Mumps virus was cultured from urine and throat specimens, identified via reverse-transcriptase polymerase chain reaction (RT-PCR) and subjected to phylogenetic analysis to identify the origin of the strain. Results: The first outbreak involved 13 high-school students (median age 14 yr): 9 who had previously received 2 doses of measles--mumps--rubella vaccine (MMR) and 4 who received a single dose. The second outbreak comprised 19 cases of mumps among students and some staff at a local university (median age 23 yr), of whom 18 had received only 1 dose of MMR (the other received a second dose). The viruses identified in the outbreaks were phylogenetically similar and belonged to a genotype commonly reported in the UK. The virus from the second outbreak is identical to the strain currently circulating in the UK and United States. Interpretation: The predominance in these outbreaks of infected people of university age not only highlights an environment with potential for increased transmission but also raises questions about the efficacy of the MMR vaccine. The people affected may represent a "lost cohort" who do not have immunity from natural mumps infection and were not offered a 2-dose schedule. Given the current level of mumps activity around the world, clinicians should remain vigilant for symptoms of mumps.
ACCESSION #
22279115

 

Related Articles

  • Wild mumps infection carries low risk of serious complications. Donegan, Jayne // Pulse;12/1/2003, Vol. 63 Issue 48, p22 

    Presents statistical data related to the occurrence of meningitis and wild mumps infection. Percentage of clinical cases of meningoencephalitis; Immunity conferred by wild mumps infection; Vaccination against mumps.

  • Resurging Virus Needs New Vaccine.  // USA Today Magazine;Oct2012, Vol. 141 Issue 2809, p5 

    The article highlights the views of professor Biao He of the University of Georgia in Athens about the need to produce a new mumps vaccine to control the emerging new strain of the virus which was spreading even among people who had received the two-dose Jeryl Lynn vaccine in their early childhood.

  • The Rat-Based Neurovirulence Safety Test for the Assessment of Mumps Virus Neurovirulence in Humans: An International Collaborative Study. Rubin, Steven A.; Afzal, Muhammad A.; Powell, Caroline L.; Bentley, Maureen L.; Auda, Ghazi R.; Taffs, Rolf E.; Carbone, Kathryn M. // Journal of Infectious Diseases;4/1/2005, Vol. 191 Issue 7, p1123 

    Because of the highly neurotropic and neurovirulent properties of wild-type mumps viruses, most national regulatory organizations require neurovirulence testing of virus seeds used in the production of mumps vaccines. Such testing has historically been performed in monkeys; however, some data...

  • Effectiveness of a vaccination program against mumps in Ukraine. Hrynash, Y.; Nadraga, A.; Dasho, M. // European Journal of Clinical Microbiology & Infectious Diseases;Dec2008, Vol. 27 Issue 12, p1171 

    Medical records and incidence data were analyzed retrospectively to document the epidemiology, clinical features, and outcomes of mumps in relation to vaccination status in the Lviv province of Ukraine over a 7.5-year period, beginning in 2000, when a second dose of mumps vaccine was introduced....

  • Características clínicas e laboratoriais da meningite asseéptica associada à vacina tríplice viral. Lucena, Rita; Gomes, Irenio; Nunes, Luciana; Cunha, Sergio; Dourado, Ines; da Gloria Teixeira, Maria; Goes, Julieta; Cardoso, Eduardo; Rodrigues, Bernardo; Cardoso, Adriana; Barreto, Mauricio L.; Melo, Ailton // Revista Panamericana de Salud Publica;Oct2002, Vol. 12 Issue 4, p258 

    Describes the epidemiological, clinical and cerebrospinal fluid findings in cases of aseptic meningitis associated with measles-mumps-rubella vaccination following a mass immunization in the Brazilian state of Bahia in August 1997. Comparison of the cases to cases of aseptic meningitis not...

  • Tackling the resurgence in mumps. Baxter, David // Pulse;11/22/2004, Vol. 64 Issue 46, p40 

    This article reports that the country-wide outbreak started several years ago and so far there have been 3,756 confirmed cases in the first nine months of 2004 compared with just over 372 in 1999; the cause is in part due to how the MMR (measles, mumps, and rubella) programme was implemented in...

  • Mumps disease outbreak in Davangere district of Karnataka, India. Raut, C. G.; Sinha, D. P.; Jayaprakash, H.; Hanumiah, H.; Manjunatha, M. J. // Indian Journal of Medical Microbiology;Jul-Sep2015, Vol. 33 Issue 3, p378 

    Background: Mumps is a vaccine-preventable disease that usually occurs as a parotitis, but it can also lead to several life- threatening complications, including pancreatitis, meningitis and encephalitis. Objective: To determine and diagnosis of mumps disease, which is communicable disease...

  • Mumps Outbreaks in Canada and the United States: Time for New Thinking on Mumps Vaccines. Peltola, Heikki; Kulkarni, Prasad S.; Kapre, Subhash V.; Paunio, Mikko; Jadhav, Suresh S.; Dhere, Rajeev M. // Clinical Infectious Diseases;8/15/2007, Vol. 45 Issue 4, p459 

    Mumps epidemics in Canada and the United States prompted us to review evidence for the effectiveness of 5 different vaccine strains. Early trials with the Jeryl Lynn vaccine strain demonstrated an efficacy of ∼95%, but in epidemic conditions, the effectiveness has been as low as 62%; this...

  • Mumps Complications and Effects of Mumps Vaccination, England and Wales, 2002-2006. Chee-Fu Yung; Andrews, Nick; Bukasa, Antoaneta; Brown, Kevin E.; Ramsay, Mary // Emerging Infectious Diseases;Apr2011, Vol. 17 Issue 4, p661 

    We analyzed data from hospital admissions and enhanced mumps surveillance to assess mumps complications during the largest mumps outbreak in England and Wales, 2004-2005, and their association with mumps vaccination. When compared with nonoutbreak periods, the outbreak was associated with a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics